Zyclara
Term · Oncology and biomedicine · MLC-T-ONC-009501
A drug that contains the active ingredient imiquimod and is used to treat certain skin conditions. Zyclara is used to treat actinic keratosis (a skin condition that may become cancer) in adults who have a normal immune system. It is also used to treat genital warts or perianal warts in adults and in children aged 12 years or older. Zyclara may help the immune system kill abnormal cells. It is a type of immunomodulating agent.
| Identifier | MLC-T-ONC-009501 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009501",
"term": "Zyclara",
"field": "Oncology and biomedicine",
"definition": "A drug that contains the active ingredient imiquimod and is used to treat certain skin conditions. Zyclara is used to treat actinic keratosis (a skin condition that may become cancer) in adults who have a normal immune system. It is also used to treat genital warts or perianal warts in adults and in children aged 12 years or older. Zyclara may help the immune system kill abnormal cells. It is a type of immunomodulating agent.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/zyclara/"
}
Record 17,708 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.